Cardio Diagnostics Holdings, Inc.CDIOEarnings & Financial Report
Cardio Diagnostics Holdings, Inc. is a precision cardiovascular healthcare company that develops and commercializes integrated genetic and epigenetic diagnostic tests for early detection of coronary heart disease, heart failure, and other cardiovascular conditions. It primarily serves healthcare providers, clinical laboratories, and patients across the United States, focusing on delivering accessible, personalized cardiovascular care solutions.
Revenue
$7.9K
Gross Profit
N/A
Operating Profit
$-1.3M
Net Profit
$-1.3M
Gross Margin
N/A
Operating Margin
-16295.6%
Net Margin
-16365.9%
YoY Growth
356.2%
EPS
$-1.71
Cardio Diagnostics Holdings, Inc. Q2 FY2024 Financial Summary
Cardio Diagnostics Holdings, Inc. reported revenue of $7.9K (up 356.2% YoY) for Q2 FY2024, with a net profit of $-1.3M (up 68.0% YoY) (-16365.9% margin).
Key Financial Metrics
| Total Revenue | $7.9K |
|---|---|
| Net Profit | $-1.3M |
| Gross Margin | N/A |
| Operating Margin | -16295.6% |
| Report Period | Q2 FY2024 |
Cardio Diagnostics Holdings, Inc. Annual Revenue by Year
Cardio Diagnostics Holdings, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $34.9K).
| Year | Annual Revenue |
|---|---|
| 2024 | $34.9K |
Cardio Diagnostics Holdings, Inc. Quarterly Revenue & Net Profit History
Cardio Diagnostics Holdings, Inc. results over the last 7 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $3.6K | -21.2% | N/A | N/A |
| Q3 FY2025 | $2.9K | -56.6% | $-1.7M | -60053.8% |
| Q2 FY2025 | $7.5K | -5.0% | $-1.7M | -22517.7% |
| Q4 FY2024 | $4.5K | -15.0% | N/A | N/A |
| Q3 FY2024 | $6.6K | -34.4% | $-1.4M | -21467.6% |
| Q2 FY2024 | $7.9K | +356.2% | $-1.3M | -16365.9% |
| Q1 FY2024 | $15.9K | — | $-4.2M | -26140.0% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $15928 | $7870 | $6580 | $4512 | $7475 | $2855 | $3555 |
| YoY Growth | N/A | 356.2% | -34.4% | -15.0% | -5.0% | -56.6% | -21.2% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Assets | $4.3M | $4.0M | $4.5M | $10.6M | $10.4M | $8.8M | $7.8M |
| Liabilities | $1.3M | $922529 | $795276 | $1.1M | $671848 | $637331 | $793061 |
| Equity | $3.0M | $3.1M | $3.7M | $9.6M | $9.7M | $8.2M | $7.0M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $-1.2M | $-1.2M | $-1.2M | $-5.0M | $-1.6M | $-1.4M | $-5.7M |